3 Takeaways From First Xarelto Trial
A verdict for the defense in the first bellwether case over allegations that blood-thinner drug Xarelto causes excessive bleeding comes as a big boost for Janssen and Bayer, who are staring...To view the full article, register now.
Already a subscriber? Click here to view full article